[At the begining of the 22d therapy-week. A press conference on a new antirheumatic agent].
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014227:Triazines
Am Rande der 22. Therapiewoche. Pressekonferenz über ein neues Antirheumatikum.